FDA Approves First Drug Targeted At Treating Postpartum Depression

The 60-hour brexanolone infusion treatment is expected to be available starting in June.

From https://www.huffpost.com/entry/fda-drug-postpartum-depression-brexanolone_n_5c91aad3e4b0dbf58e45a92d

from
https://healthnews010.wordpress.com/2019/03/20/fda-approves-first-drug-targeted-at-treating-postpartum-depression/

from https://karlfletcher.blogspot.com/2019/03/fda-approves-first-drug-targeted-at.html

from
https://karlfletcher1.tumblr.com/post/183583065298